NCT01258205 - Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

February 18, 2015

Study Completion Date

February 18, 2015

Conditions

Crohn's Disease

Interventions

DRUG

AMG 139

Four dose levels of AMG 139 administered as multiple doses IV or SC in healthy volunteers (Part A) and subjects with moderate-severe Crohn's disease (Part B).

Trial Locations (7)

3181

Centre for Clinical Studies (Alfred), Prahran

4029

QPharm Pty Limited, Herston

5000

Clinical Medical and Analytical eXellence CMAX, Adelaide

11794

Stony Brook University Medical Center, Stony Brook

23291

Virginia Commonwealth University, Richmond

73102

Oklahoma Foundation for Digestive Research, Oklahoma City

08009

Comprehensive Clinical Research, Berlin